Science Explorer Interactive view Map
Company · South San Francisco · United States

Lyell Immunopharma (United States)

lyell.comROR OpenAlex
Research works
29
▲ 6820% vs 2013–17
Citations
824
28.1 per fractional work
Top-10% rate
4.0%
record average 16.5%
Open access
66%
world 28%

Not ranked overall: Lyell Immunopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.31× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 13.59× its world share, 3 worksImmunology and Micro…Neuroscience: 1.49× its world share, 0 worksNeuroscienceEarth and Planetary Sciences: 0.13× its world share, 0 worksEarth and Planetary …Engineering: 0.21× its world share, 1 worksEngineeringMathematics: 1.23× its world share, 0 worksMathematicsMedicine: 2.92× its world share, 12 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.6×. Every wedge is a field page.

Which keywords describe research at Lyell Immunopharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Immunity, Antigen Presentation and Dendritic Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Cancer Immunotherapy10▲ 321×2 topics
  2. Immunotherapy10▲ 65×3 topics
  3. Tumor Regression10▲ 419×2 topics
  4. CAR T Cells8▲ 557×1 topic
  5. Chimeric Antigen Receptor8▲ 557×1 topic
  6. Antigen Presentation2▲ 96×2 topics
  7. Immunity2▲ 21×2 topics
  8. Dendritic Cells2▲ 92×1 topic
  9. Tumor Antigen2▲ 134×1 topic
  10. Cell Culture2▲ 64×2 topics
  11. Glycosylation2▲ 65×2 topics
  12. Gene Therapy1▲ 35×3 topics
  13. Monoclonal Antibody1▲ 122×2 topics
  14. Bacterial Therapy1▲ 135×1 topic
  15. Transcriptional Regulation1▲ 31×3 topics
  16. Tumor Targeting1▲ 27×1 topic

Which research topics does Lyell Immunopharma (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, Viral Infectious Diseases and Gene Expression in Insects and Cancer Research and Treatments.

CAR-T cell therapy resea…8CAR-T cell therapy research: 8 fractional worksImmunotherapy and Immune Responses: 2 fractional worksViral Infectious Diseases and Gene Expression in Insects: 1 fractional worksCancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksCRISPR and Genetic Engineering: 1 fractional worksSingle-cell and spatial transcriptomics: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksNuclear Receptors and Signaling: 0 fractional worksPluripotent Stem Cells Research: 0 fractional works3D Printing in Biomedical Research: 0 fractional works
OncologyImmunologyMolecular BiologyBiotechnology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 8 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 1 works
  4. 4 Cancer Research and Treatments Biotechnology 1 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 1 works
  6. 6 Single-cell and spatial transcriptomics Molecular Biology 1 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
  8. 8 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  9. 9 Pluripotent Stem Cells Research Molecular Biology 0 works
  10. 10 3D Printing in Biomedical Research Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.7%not open34.3%

World: 28% of research is openly available.

with international co-authors17.4%domestic only82.6%

World: 19% is written across borders.

How has Lyell Immunopharma (United States)'s research output changed?

Output in 2018–2022 was 6820% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.